{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:58:53Z","timestamp":1780970333958,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.surg.2026.110208","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:23:03Z","timestamp":1776525783000},"page":"110208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Postoperative risk stratification using calcitonin doubling rate in medullary thyroid carcinoma with biochemical persistent disease"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-6602","authenticated-orcid":false,"given":"Masashi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Miya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110208_bib1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1097-0142(19920815)70:4<808::AID-CNCR2820700415>3.0.CO;2-L","article-title":"Analysis of thyroid carcinoma based on material registered in Japan during 1977\u20131986 with special reference to predominance of papillary type","volume":"70","author":"Ezaki","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2026.110208_bib2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2026.110208_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2265.2009.03666.x","article-title":"Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis","volume":"72","author":"Meijer","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.surg.2026.110208_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2014.0277","article-title":"Response to initial therapy predicts clinical outcomes in medullary thyroid cancer","volume":"25","author":"Lindsey","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2026.110208_bib5","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1007\/s00268-018-4738-z","article-title":"Static prognostic factors and appropriate surgical designs for patients with medullary thyroid carcinoma","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2026.110208_bib6","first-page":"6(Suppl 1)","article-title":"Postoperative follow up in patients showing no evident residual disease - cut-offs for imaging\/intervention","volume":"14","author":"Minuto","year":"2013","journal-title":"Thyroid Res"},{"key":"10.1016\/j.surg.2026.110208_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12957-024-03527-x","article-title":"Survival in medullary thyroid carcinoma patients who fail to achieve a biochemical cure: implications of postoperative 1-month calcitonin levels and targeted therapy","volume":"22","author":"Song","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.surg.2026.110208_bib8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12020-024-03809-0","article-title":"Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study","volume":"85","author":"Zuhur","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.surg.2026.110208_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/thy.2022.0295","article-title":"An undetectable postoperative calcitonin level is associated with long-term disease-free survival in medullary thyroid carcinoma","volume":"33","author":"da Silveira Duval","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2026.110208_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5","article-title":"Long-term follow-up of patients with medullary carcinoma of the thyroid","volume":"79","author":"Bergholm","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2026.110208_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/thy.1996.6.305","article-title":"Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control","volume":"6","author":"Brierley","year":"1996","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2026.110208_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00000658-198404000-00014","article-title":"Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma","volume":"199","author":"Miyauchi","year":"1984","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2026.110208_bib13","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2005-0044","article-title":"Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma","volume":"90","author":"Barbet","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2026.110208_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-07-0667","article-title":"Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times","volume":"158","author":"Giraudet","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2026.110208_bib15","first-page":"1193","article-title":"Tumor grade predicts for calcitonin doubling times and disease-specific outcomes after resection of medullary thyroid carcinoma","volume":"32","author":"Nigam","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2026.110208_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.surg.2018.07.045","article-title":"Natural history of papillary thyroid microcarcinoma: kinetic analyses on tumor volume during active surveillance and before presentation","volume":"165","author":"Miyauchi","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110208_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13044-020-00087-6","article-title":"Kinetic analysis of the growth rate of sporadic and hereditary medullary thyroid carcinoma: comparing the postoperative calcitonin-doubling rate with the hypothetical preoperative tumor volume-doubling rate","volume":"21","author":"Kihara","year":"2020","journal-title":"Thyroid Res"},{"key":"10.1016\/j.surg.2026.110208_bib18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s002680010226","article-title":"Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma","volume":"24","author":"Miyauchi","year":"2000","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2026.110208_bib19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00268-002-6665-1","article-title":"Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations","volume":"26","author":"Miyauchi","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2026.110208_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00268-008-9795-2","article-title":"Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution","volume":"33","author":"Ito","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2026.110208_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1507\/endocrj.EJ16-0107","article-title":"Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay","volume":"63","author":"Kihara","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.surg.2026.110208_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00595-017-1578-7","article-title":"Serum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma","volume":"48","author":"Kihara","year":"2018","journal-title":"Surg Today"},{"key":"10.1016\/j.surg.2026.110208_bib23","first-page":"4251","article-title":"Association of basal and calcium-stimulated calcitonin levels with pathological findings after total thyroidectomy","volume":"35","author":"Papadakis","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.surg.2026.110208_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1507\/endocrj.K10E-359","article-title":"Serum calcitonin levels with calcium loading tests before and after total thyroidectomy","volume":"58","author":"Kudo","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.surg.2026.110208_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/thy.2006.0338","article-title":"Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens","volume":"17","author":"Kudo","year":"2007","journal-title":"Thyroid"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026001303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026001303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:03:20Z","timestamp":1780967000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026001303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S0039606026001303"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110208","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative risk stratification using calcitonin doubling rate in medullary thyroid carcinoma with biochemical persistent disease","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110208"}}